Cardinal Health (CAH) Q4 FY26 — revenue $63.7B (+6% Y/Y), non-GAAP EPS $2.91 (+40% Y/Y) tops $2.42 est on higher segment profits + one-time <meta name="viewport" content="width=device-width, initial-scale=1.0" />00M IEEPA tariff refund; FY27 non-GAAP EPS guide <meta name="viewport" content="width=device-width, initial-scale=1.0" />2.40–<meta name="viewport" content="width=device-width, initial-scale=1.0" />2.60 (+13

2.40–2.60 (+13–15%), plus a fresh $5B buyback authorization." /> 00M IEEPA tariff refund; FY27 non-GAAP EPS guide 2.40–2.60 (+13–15%) with $5B new buyback authorization" /> 2.40–2.60 (+13–15%), plus a fresh $5B buyback authorization." /> 00M IEEPA tariff refund; FY27 non-GAAP EPS guide 2.40–2.60 (+13–15%) with $5B new buyback authorization" /> 2.40–2.60 (+13–15%), plus a fresh $5B buyback authorization." />

Stock/TLDR — What Just Moved Markets: Earnings, Fed, M&A, MoversA high-volume feed of market-moving releases — quarterly earnings, FOMC decisions, M&A, regulatory actions, big single-name moves, macro prints, commodities and crypto — refreshed every 12 hours. Each release is explained in plain English so you actually understand what just happened and which tickers it touches.This site uses JavaScript to render the interactive feed. Enable JavaScript to use it.Stock/TLDR is not investment advice. Verify everything against primary sources before trading.